We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio Adolescents with type 2 diabetes were ...

Sept. 15, 2005 (Athens) — Exenatide can achieve glycemic control equivalent to insulin glargine in type 2 diabetes patients also treated with metformin and a sulfonylurea, according to a study ...

Since May 2007, a new drug has been available for the treatment of patients with diabetes mellitus type 2 in Germany: exenatide (trade name: Byetta®), which is marketed by the manufacturer Eli Lilly.

Non-motor symptoms of Parkinson's disease (PD), such as depression, apathy, cognitive impairment, sleep disorders, and sensory symptoms, can have a greater impact on health-related quality of life ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio Adults with type 2 diabetes initially ...

Amsterdam, NL, August 1, 2018 - Non-motor symptoms of Parkinson's disease (PD), such as depression, apathy, cognitive impairment, sleep disorders, and sensory symptoms, can have a greater impact on ...

Exenatide is a generic prescription drug approved to help manage blood sugar levels in adults with type 2 diabetes. It’s not available in a brand-name version. Exenatide comes as a liquid solution ...

Twice-daily exenatide may offer advantages over the standard glimepiride in patients with Type 2 diabetes inadequately controlled by metformin, suggest findings published in The Lancet. The study ...

Male Harlan-Sprague-Dawley rats were treated with high-fat diet/streptozotocin to induce type 2 diabetes. After subcutaneous administration of a single dose of exenatide (4.2, 42, or 210 μg/kg), serum ...

Privately held Intarcia Therapeutics Inc.'s subcutaneous, osmotic-pump method of delivering the glucagon-like peptide-1 receptor agonist exenatide will enter Phase III trials in the first quarter of ...